Patent details
EP2221376 Title: Antisense modulation of superoxide dismutase 1, soluble expression
Basic Information
- Publication number:
- EP2221376
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP100751965
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Antisense modulation of superoxide dismutase 1, soluble expression
- French Title of Invention:
- Modulation anti-sens d'expression soluble de superoxide dismutase 1
- German Title of Invention:
- Antisense-Modulation von Superoxid-Dismutase 1, Expression in Lösung
- SPC Number:
Dates
- Filing date:
- 19/06/2002
- Grant date:
- 21/11/2012
- EP Publication Date:
- 21/11/2012
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 25/08/2010
- EP B1 Publication Date:
- 21/11/2012
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 19/06/2013
- Expiration date:
- 19/06/2022
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 19/06/2002
- Name:
- Isis Pharmaceuticals Inc.
- Address:
- 2855 Gazelle Court, Carlsbad, CA 92010, United States (US)
Inventor
1
- Name:
- Dobie Kenneth
- Address:
- United States (US)
2
- Name:
- Bennett C. Frank
- Address:
- United States (US)
Priority
- Priority Number:
- 888360
- Priority Date:
- 21/06/2001
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- C12N 15/11;
| Filing date | Document type | Number of pages |
|---|